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Abstract
Regulation of the number of ion channels at the plasma membrane is a critical component of the physiological response.
We recently demonstrated that the Ca2+-activated K+ channel, KCa2.3 is rapidly endocytosed and enters a Rab35- and
EPI64C-dependent recycling compartment. Herein, we addressed the early endocytic steps of KCa2.3 using a combination of
fluorescence and biotinylation techniques. We demonstrate that KCa2.3 is localized to caveolin-rich domains of the plasma
membrane using fluorescence co-localization, transmission electron microscopy and co-immunoprecipitation (co-IP).
Further, in cells lacking caveolin-1, we observed an accumulation of KCa2.3 at the plasma membrane as well as a decreased
rate of endocytosis, as assessed by biotinylation. We also demonstrate that KCa2.3 and dynamin II are co-localized following
endocytosis as well as demonstrating they are associated by co-IP. Further, expression of K44A dynamin II resulted in a 2-
fold increase in plasma membrane KCa2.3 as well as a 3-fold inhibition of endocytosis. Finally, we evaluated the role of Rab5
in the endocytosis of KCa2.3. We demonstrate that expression of a dominant active Rab5 (Q79L) results in the accumulation
of newly endocytosed KCa2.3 on to the membrane of the Rab5-induced vacuoles. We confirmed this co-localization by co-
IP; demonstrating that KCa2.3 and Rab5 are associated. As expected, if Rab5 is required for the endocytosis of KCa2.3,
expression of a dominant negative Rab5 (S34N) resulted in an approximate 2-fold accumulation of KCa2.3 at the plasma
membrane. This was confirmed by siRNA-mediated knockdown of Rab5. Expression of the dominant negative Rab5 also
resulted in a decreased rate of KCa2.3 endocytosis. These results demonstrate that KCa2.3 is localized to a caveolin-rich
domain within the plasma membrane and is endocytosed in a dynamin- and Rab5-dependent manner prior to entering the
Rab35/EPI64C recycling compartment and returning to the plasma membrane.
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Introduction
The small conductance, Ca2+-activated K+ channel, KCa2.3
has been shown to play a critical role in a wide array of
physiological processes [1–3]. The physiological response of any
cell, with regard to ion channels, is determined by total current
flow across the plasma membrane (I), which is in turn dictated by
both the likelihood that the channels are in the open and
conducting state, i.e., the open probability of the channel (Po) and
the number of channels in the plasma membrane during
stimulation (N) such that I a NPo. While a great deal has been
learned about the regulation of KCa2.x and the related family
member, KCa3.1 in terms of altering Po [4–11] much less
information exists regarding the mechanisms by which N is
determined. We [9,12–14] and others [15–17] have identified
numerous motifs in the N- and C-termini of KCa family members
which are required for the proper assembly and anterograde
trafficking of these channels to the plasma membrane. Only
recently, however, have reports begun to emerge that delve in to
the mechanisms by which KCa2.x and KCa3.1 channels are
endocytosed from the plasma membrane.
Recently, we published a series of studies demonstrating that
KCa3.1 is rapidly endocytosed and targeted for lysosomal
degradation [18–20] and that this lysosomal targeting requires
ubiquitylation and USP8-mediated deubiquitylation [20]. Schwab
and colleagues [21] have confirmed a rapid endocytosis of KCa3.1
in migrating MDCK cells and suggested this was clathrin-
dependent. In contrast, we demonstrated that KCa2.3 is rapidly
endocytosed and recycled back to the plasma membrane in
a Rab35/EPI64C/RME-1-dependent manner in both HEK cells
and HMEC-1 endothelial cells [18]. Absi et al. [22] have further
shown that KCa2.3 resides in a caveolin-rich membrane domain
in endothelial cells, although the endocytosis from this domain was
not assessed. Herein, we demonstrate that the endocytosis of
KCa2.3 from the plasma membrane is dependent upon caveolin-1
and dynamin II as well as Rab5, and that perturbation of these
pathways leads to increased plasma membrane KCa2.3 as a result
of a reduced endocytic rate. Taken together with previous studies,
we propose that KCa2.3 is localized to caveolae, is endocytosed in
a dynamin II- and Rab5-dependent manner after which KCa2.3
enters a recycling endosome compartment and is returned to the
plasma membrane in a Rab35/EPI64C/RME-1-dependent
manner [18].
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Materials and Methods
Molecular Biology
The biotin ligase acceptor peptide (BLAP)-tagged KCa2.3
construct has been previously described [18]. For the generation of
recombinant adenovirus (E1/E3-deleted) expressing BLAP-
KCa2.3 the epitope-tagged channel was subcloned in to pAdlox.
The myc-tagged KCa2.3 was a generous gift from J.P. Adelman
(Vollum Institute, Oregon Health Sciences University), whereas
the WT and K44A GFP-tagged dynamin II constructs were
generously provided by N.A. Bradbury (Chicago Medical School).
Rab5 was obtained as Addgene plasmid 14437 as provided by A.
Helenius [23] and DsRed-Rab5 was obtained as Addgene plasmid
13051 as provided by R.E. Pagano [24]. GTP-bound, dominant
active (Q79L) and GDP-bound, dominant negative (S34N) Rab5
mutations were generated using the Stratagene QuikChangeTM
site-directed mutagenesis strategy (Stratagene, La Jolla, CA). The
fidelity of all constructs utilized in this study were confirmed by
sequencing (ABI PRISM 377 automated sequencer, University of
Pittsburgh).
Cell Culture
Human embryonic kidney (HEK293) cells were obtained from
the American Type Culture Collection (Manassas, VA) and
cultured in Dulbecco’s modified Eagle’s medium (DMEM;
Invitrogen, Carlsbad, CA) supplemented with 10% fetal bovine
serum and 1% penicillin-streptomycin in a humidified 5% CO2/
95% O2 incubator at 37uC. Cells were transfected using
LipofectAMINE 2000 (Invitrogen) following the manufacturer’s
instructions.
Wild-type (WT) and caveolin-1-deficient [Cav-1(2/2)] mouse
embryonic fibroblasts (MEFs) cells were kindly provided by Dr.
Carolyn Coyne (University of Pittsburgh) and cultured in high
glucose Dulbecco’s modified Eagle’s medium supplemented with
10% fetal bovine serum and 1% penicillin-streptomycin in
a humidified 5% CO2/95% O2 incubator at 37uC. WT and
Cav-1(2/2) MEFs cells were infected with a recombinant
adenovirus expressing BLAP-tagged KCa2.3 (BLAP-KCa2.3-Ad)
generated by the University of Pittsburgh Vector Core. Brieftly,
MEFs cells were washed three times with 37uC PBS, followed by
incubation with BLAP-KCa2.3-Ad for 30 min at 37uC. Then,
cells were washed once with PBS and allowed to recover until the
next day in normal growth media.
Antibodies
a-KCa2.3 Ab was obtained from Chemicon (Temecula, CA), a-
myc Ab (9E10) was obtained from Covance (Richmond, CA), a-
Rab5 Ab was obtained from Abcam (Cambridge, MA), a-GFP Ab
was obtained from Santa Cruz Biotechnology (Santa Cruz, CA),
a-tubulin Ab was obtained from Sigma-Aldrich (St. Louis, MO)
and a-V5 Ab was obtained from Invitrogen.
Biotinylation of KCa2.3 Using BirA
Biotin ligase (BirA) was expressed from pET21a-BirA (gener-
ously provided by Dr. Alice Y. Ting, Massachusetts Institute of
Technology, Cambridge, MA) in E. coli as previously described
[18]. HEK293 or WT and Cav-1(2/2) MEFs cells expressing
BLAP-tagged KCa2.3 were incubated in PBS containing BirA
(0.03 mg/ml), 10 mM ATP, 50 mM biotin, 1 mM Ca2+ and 2 mM
Mg2+ for 30 min at room temperature. The cells were then
washed 3x with PBS to remove the BirA and incubated in PBS
containing 1% BSA plus appropriately fluorescently tagged
streptavidin-Alexa488 or streptavidin-Alexa555 (0.01 mg/ml) for
10 min at 4uC. The cells were extensively washed with PBS/BSA
to remove unbound streptavidin and then either incubated for
various periods of time as indicated in the text at 37uC or
immediately fixed and permeabilized with 2% paraformaldehyde
plus 0.1% Triton X-100. BLAP-tagged KCa2.3 was also co-
expressed with DsRed-tagged WT, S34N or Q79L Rab5. In other
experiments, BLAP-KCa2.3 and GM1 (a marker for lipid rafts)
were simultaneously labeled at the plasma membrane using
streptavidin-555 and the cholera toxin B-subunit (CTX-B)
conjugated to Alexa488 (1ug/ml) for 30 min at 4uC, respectively
[25,26]. Nuclei were labeled with DAPI. Cells were imaged by
laser confocal microscopy using an Olympus FluoView 1000. To
ensure maximal X-Y spatial resolution, sections were scanned at
1,02461,024 pixels, using sequential three-color image collection
to minimize cross talk between the channels imaged.
Live-cell Confocal Microscopy
HEK293 cells were grown in a 35 mm glass-bottom dish (Mat-
Tek Co) and co-transfected with BLAP-KCa2.3 and GFP-tagged
WT dynamin II. Cells were incubated 10 min at 4uC with
streptavidin-Alexa555 to label cell surface KCa2.3, as above and
then returned to normal media. The dishes were then immediately
transferred to a heated (37uC) chamber and imaged by laser
confocal microscopy using an Olympus FluoView 1000 with 60x
oil objective (plan apochromat, numerical aperture 1.4). 30–60
images were taken at 50 sec intervals. Images were processed using
FV10-ASW version 02.01 (Olympus) and Photoshop version CS4
(Adobe).
Total KCa2.3 Plasma Membrane Expression and
Endocytosis Assay
Cell surface proteins, including KCa2.3, were biotinylated using
EZ-Link Sulfo-NHS-SS-Biotin (Thermo Scientific, Rockford, IL)
for 30 min at 4uC, after which the un-reacted biotin was quenched
(PBS plus 1% BSA). For analysis of plasma membrane expression
these samples were then immediately subject to cell lysis (50 mM
HEPES pH 7.4, 150 mM NaCl, 1% v/v Triton X-100, 1 mM
EDTA containing CompleteTM EDTA-free protease inhibitor
cocktail mix, Roche Applied Science, Indianapolis, IN) and
streptavidin-agarose (Sigma-Aldrich) pulldown following normal-
ization of protein concentrations and finally SDS-PAGE analysis.
To evaluate endocytosis, the biotinylated samples were warmed to
37uC to allow channel endocytosis for various periods of time, as
indicated. The remaining cell surface biotin was stripped using
MESNA (100 mM sodium 2-mercaptoethanesulfonate, 50 mM
Tris, 100 mM NaCl, 1 mM EDTA, 0.2% BSA) after which the
cells were lysed and the protected (endocytosed) biotin-tagged
channels subject to pulldown using streptavidin-agarose following
normalization of protein concentrations. The endocytosed samples
were compared to samples which were either biotinylated and
immediately subject to lysis and streptavidin pulldown (total cell
surface KCa2.3) or biotinylated and immediately stripped to
confirm the efficiency of the MESNA stripping step (strip control).
Proteins were resolved by SDS-PAGE (8% gel) and transferred to
nitrocellulose for immunoblot analysis.
Immunoprecipitations (IP) and Immunoblots (IB)
Our IP and IB protocols have been previously described [20–
22]. Briefly, cells were lysed and equivalent amounts of total
protein were precleared with protein G-agarose beads (Invitrogen),
and incubated with the indicated antibody. A non-specific IgG was
used as negative control. Immune complexes were precipitated
with protein G-agarose beads, the proteins resolved by SDS-
PAGE followed by IB. To eliminate interference by the heavy and
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PLOS ONE | www.plosone.org 2 August 2012 | Volume 7 | Issue 8 | e44150
light chains of the immunoprecipitating antibody in the IP, mouse
IgG TrueblotTM ULTRA (eBioscience, San Diego, CA) was used
as a secondary antibody for the detection of immunoprecipitated
proteins in the IB. Relative protein levels were quantified by
densitometry using Quantity One software (Bio-Rad, Hercules,
CA).
Short-interfering RNA Treatment (siRNA)
The siRNA against the coding region of human Rab5 was
obtained from Ambion (Grand Island, NY). The siGENOME
Non-Targeting siRNA Pool no. 2 (Dharmacon Research,
Chicago, IL) was used as control. HEK293 cells, stably expressing
KCa2.3, were plated at ,50% confluence and transfected with
a mix of 50 nM Rab5 A, B and C siRNA duplexes using
DharmaFECT 1, according to the manufacturer’s directions.
Experiments were carried out 72 hrs post-transfection.
Transmission Electron Microscopy (TEM) of Quantum Dot
Labeled KCa2.3
HEK293 cells stably expressing KCa2.3 were grown on plastic
coverslips for 24 hrs after which the channel was enzymatically
biotinylated at the cell surface as described above, then labeled
with streptavidin conjugated with QuantumDot-655 (Invitrogen).
These QDots can be visualized in electron micrographs as dense
geometric structures [19]. Following incubation at 37uC, the cells
were fixed in 2.5% glutaraldehyde in PBS for 1 hr at room
temperature. Samples were rinsed three times for five min in PBS
and postfixed in 1% osmium tetroxide containing 1% potassium
ferricyanide for 1 hour at room temprature and then rinsed three
times in PBS. The cells were dehydrated in ascending grades of
ethanol (30%, 50%, 70%, 90%) 10 min. each, and three changes
of absolute alcohol for 15 min at room temperature. Samples were
infiltrated three times with epon (1 hr each). Samples were
embedded in epon overnight at 37uC and then 48 hrs at 65uC.
Ultra thin sections were mounted on grids and stained in 2%
Figure 1. KCa2.3 is located in a caveolin-rich plasma membrane domain. A. BLAP-tagged KCa2.3 was expressed in HEK293 cells and labeled
at the plasma membrane with streptavidin-Alexa555 (left panel), while lipid rafts were localized using the cholera toxin B-subunit (CTX-B) labeled with
Alexa488 (middle panel). Top Panels. Single confocal section at the interface where the cells are attached to the glass coverslip showing extensive
co-localization between KCa2.3 and CTX-B (merge) at T = 0 min. Bottom Panels. Single mid-plane confocal section after 30 min at 37uC showing
endocytosed KCa2.3 co-localized with CTX-B (arrowheads in merge), indicating KCa2.3 is endocytosed in caveolae with CTX-B. B. Transmission
Electron Micrograph (TEM) of Quantum Dot-labeled KCa2.3 following endocytosis for 30 min at 37uC. Electron-dense Quantum Dots are observed in
structures consistent with caveolae (Cav). A clathrin coated vesicle (CCV) is indicated for comparison. C. Co-IP of KCa2.3 with GFP-tagged caveolin-1
was carried out in HEK293 cells as described in the Methods. Caveolin-1 was immunoprecipitated using an anti-GFP Ab (lanes 1, 2, 4) or an anti-V5 Ab
as IgG control (lane 3) and subsequently IB using an anti-KCa2.3 Ab. When only a single construct was transfected the empty vector (vec) was
included to maintain the plasmid at the same final concentration. KCa2.3 was detected by IB in lane 4, confirming an association between KCa2.3 and
caveolin-1 (Top Panel). Bottom Panel confirms expression of KCa2.3 in total lysate by IB (5 mg total protein loaded per lane). Data are representative of
3 experiments.
doi:10.1371/journal.pone.0044150.g001
Endocytosis of KCa2.3
PLOS ONE | www.plosone.org 3 August 2012 | Volume 7 | Issue 8 | e44150
uranyl acetate in methanol and then 1% lead citrate before
imaging with a JEOL 1011 (Joel, Tokyo, Japan) electron
microscope operated at an accelerating voltage of 80 kV.
Chemicals
All chemicals were obtained from Sigma-Aldrich, unless
otherwise stated.
Statistics
All data are presented as means 6 SEM, where n indicates the
number of experiments. Statistical analysis was performed using
a Student’s t test. To compare the normalized values of the IB
band intensities, statistical analysis was performed using the non-
parametric Kruskal-Wallis test. A value of p,0.05 is considered
statistically significant and is reported.
Results
KCa2.3 is Localized to Caveolae in HEK293 Cells
Absi et al. [22] previously demonstrated that KCa2.3 is
localized to a caveolin-rich, plasma membrane subdomain in
endothelial cells and further demonstrated that KCa2.3 and
caveolin could be co-IP. Thus, prior to evaluating downstream
endocytic events we confirmed that KCa2.3 is localized to
caveolae using the HEK293 model system. Initially, we addressed
this by labeling BLAP-KCa2.3 at the plasma membrane using
streptavidin-555 and used the cholera toxin B-subunit (CTX-B)
labeled with Alexa488 as a marker for caveolae [25,26]. As shown
in Fig. 1A, KCa2.3 co-localized with CTX-B, confirming KCa2.3
is localized to caveolae in the plasma membrane. Further, after
30 min at 37uC, KCa2.3 and CTX-B were co-localized in
endosomes (Fig. 1A), indicative of caveolae-dependent endocytosis
of the channel. We also analyzed the endocytic compartment in to
which KCa2.3 was initially retrieved by labeling KCa2.3 at the
plasma membrane with streptavidin-Quantum Dots and allowing
Figure 2. Absence of caveolin-1 decreases KCa2.3 endocytosis. A. Wild-type (WT) and caveolin-1-deficient [Cav-1(2/2)] mouse embryonic
fibroblasts (MEFs) were infected with BLAP-KCa2.3-Ad, labeled at the plasma membrane with streptavidin-Alexa555 at 4uC after which the cells were
imaged by confocal microscopy (see Methods). In Cav-1(2/2) MEFs, KCa2.3 cell surface expression appears to be significantly increased compared to
WT MEF cells. B. Plasma membrane proteins were biotinylated using EZ-Link Sulfo-NHS-SS-Biotin (see Methods) after which the cells were incubated
at 37uC for 20 min. Initial plasma membrane expression was determined by omitting the 37uC incubation step (T = 0 min, lane 2). The cell surface
biotin which remained following endocytosis was stripped (MESNA) after which the endocytosed, biotinylated protein was pulled down using
streptavidin-agarose, the proteins separated by SDS-PAGE and blotted for KCa2.3. The densitometries were determined and plotted in C. In the
absence of caveolin-1, plasma membrane KCa2.3 was increased 1.4460.16-fold (n= 3; p,0.05). Subsequently, the cell surface biotin which remained
following endocytosis was stripped (MESNA) and KCa2.3 expression evaluated as above. The efficiency of stripping was determined by subjecting
cells to MESNA in the absence of a 37uC endocytosis step (control, lane 1). Lane 3 demonstrates the amount of KCa2.3 endocytosed in 20 min
(T = 20 min). The ratio between the amount of KCa2.3 detected following endocytosis (lane 3) to that at time 0 (lane 2) was determined by
densitometry and plotted as % endocytosis in D. Knockout of caveolin-1 (Cav-1(2/2)) resulted in a significant decrease of KCa2.3 endocytosis,
relative to WT MEFs (n = 3; *p,0.05). Caveolin-1 knockout was confirmed by IB. Densitometry is expressed as mean 6 SEM. Tubulin was used as
a loading control.
doi:10.1371/journal.pone.0044150.g002
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the channels to endocytose for 20 min at 37uC after which the cells
were subject to TEM. As shown in Fig. 1B, KCa2.3 is observed in
vesicles with a characteristic shape associated with endocytosed
caveolae as opposed to the endosomes associated with clathrin-
mediated endocytosis [27,28]. Finally, we co-expressed KCa2.3
and GFP-tagged caveolin-1 and confirmed an association by co-IP
as shown in Fig. 1C. Taken together, these results confirm that
KCa2.3 is localized to a caveolin-rich subdomain of the plasma
membrane.
To evaluate whether caveolin-1 is involved in the cell surface
expression, as well as the endocytosis of KCa2.3, we utilized WT
and Cav-1(2/2) MEF cells. We chose MEFs for these experi-
ments as they offer a true null phenotype for caveolin-1, which was
initially confirmed by immunoblot (Fig. 2B). Initially, we evaluated
KCa2.3 expression at the plasma membrane in WT and Cav-
1(2/2) MEFs by infecting with BLAP-KCa2.3-Ad and labeling
plasma membrane channels using streptavidin-555. As shown in
Fig. 2A, cell surface expression of KCa2.3 was apparently
increased in Cav-1(2/2) MEFs compared to WT controls, as
assessed by fluorescence labeling. This result was confirmed by
biotinylation (T= 0 min.) as shown in Fig. 2B and C where
KCa2.3 was increased an average of 1.4460.16-fold (n=3;
p,0.05) in Cav-1(2/2) MEFs relative to WT MEFs; demon-
strating an accumulation of KCa2.3 at the cell surface in the
absence of caveolin-1. To evaluate whether expression of caveolin-
1 is also required for the endocytosis of KCa2.3, we determined
the fraction of channel endocytosed after 20 min in the presence
or absence of caveolin-1 (see Methods). As shown in Figs. 2B and
D, in WT MEFs 25.862.8% (n=3) of KCa2.3 was endocytosed,
whereas in the Cav-1(2/2) MEFs only 14.161.4% (n=3;
p,0.05) of KCa2.3 was endocytosed; confirming a role for
caveolin-1 in the endocytosis of KCa2.3.
KCa2.3 Endocytosis is Dynamin Dependent
Two of the major endocytic routes for proteins can be
generalized as either clathrin-dependent or –independent and
the clathrin-independent pathway can be viewed as either
dynamin-dependent or –independent [29]. As the clathrin-
independent and caveolar-dependent pathway has been shown
to be dynamin dependent, we evaluated the role of dynamin II in
the endocytosis of KCa2.3. Initially, we monitored the dynamics of
KCa2.3 by live cell imaging to determine whether KCa2.3 was
endocytosed in to dynamin II-containing vesicles. HEK293 cells
were co-transfected with BLAP-KCa2.3 and GFP-tagged WT
dynamin II and imaged as described in the Methods. In individual
images taken throughout the time-course of the experiment, we
observed that KCa2.3 and dynanin II co-localized in vesicles both
near the plasma membrane as well as deeper in the cytoplasm
(Fig. 3A), indicative of dynamin-dependent endocytosis. In
addition, when we co-expressed myc- tagged KCa2.3 with either
WT or K44A dynamin II, we were able to co-IP KCa2.3 with
both WT and K44A dynamin II (Fig. 3B), suggesting that KCa2.3
and dynamin reside within the same compartment during the
endocytic process.
As our results suggest a role for dynamin in the endocytosis of
KCa2.3, we determined whether WT or K44A dynamin II would
alter the plasma membrane expression of KCa2.3 using a standard
biotinylation approach. As shown in Figs. 4A and B, expression of
K44A dynamin II resulted in an approximately 2-fold increase in
plasma membrane KCa2.3 expression compared to WT dynamin
II (1.760.2-fold, p,0.05, n=3), further suggesting that dynamin is
required for KCa2.3 endocytosis. Finally, we directly evaluated the
effect of dynamin II on KCa2.3 endocytosis by biotinylating
KCa2.3 at the plasma membrane and determining the fraction of
KCa2.3 endocytosed after 20 min in the presence of WT or K44A
Figure 3. Endocytosis of KCa2.3 is dependent upon dynamin. A. GFP-tagged WT dynamin II and BLAP-tagged KCa2.3 were expressed in
HEK293 cells. KCa2.3 was labeled at the plasma membrane with streptavidin-Alexa555 for 10 min at 4uC after which the cells were immediately
imaged by live-cell confocal microscopy at 37uC (see Methods). Left Panels show individual images from two separate cells during the time course
of the experiment. Right Panels show cropped images from these two cells (labeled 1 and 2) as well as cropped images from 2 additional cells.
Arrows denote co-localization of KCa2.3 and WT dynamin II. B. Co-IP of myc-tagged KCa2.3 with GFP-tagged dynamin II. KCa2.3 was
immunoprecipitated using an anti-myc Ab (lanes 1, 2, 4, 5) or an anti-V5 Ab as IgG control (lane 3) and subsequently IB using an anti-GFP Ab for
dynamin II. WT and K44A dynamin II were detected by IB in lanes 4 and 5, respectively, confirming an association between KCa2.3 and dynamin (Top
Panel). Bottom Panel confirms expression of GFP-tagged dynamin in total lysate by IB (5 mg total protein loaded per lane). Data are representative of
3 experiments.
doi:10.1371/journal.pone.0044150.g003
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dynamin II (Figs. 4C and D). Similar to what we previously
observed (18), KCa2.3 is rapidly endocytosed in the presence of
WT dynamin II (30.563.4%). In contrast, K44A dynamin II
dramatically slowed the endocytosis of KCa2.3 (10.162.3%;
p,0.05, n= 3), directly demonstrating that inhibition of dynamin
function alters the endocytosis of the channel. Together, these
results demonstrate a role for dynamin in the endocytosis of
KCa2.3 in caveolae-containing vesicles.
KCa2.3 Endocytosis is Rab5 Dependent
Both Rab5 and Arf6 have been shown to play important roles in
the early endocytic steps of numerous proteins [30,31] such that
we determined whether either of these small GTPases are involved
in the endocytosis of KCa2.3. Initial expression studies using Arf6
resulted in no clear alterations in KCa2.3 plasma membrane
expression or endocytosis/localization and thus this small GTPase
was not further evaluated (data not shown). The role of Rab5 on
the endocytosis of KCa2.3 was initially evaluated by co-
transfecting either WT DsRed-Rab5 or the S34N dominant
negative or Q79L dominant active mutants with BLAP-KCa2.3
and determining the localization of the channel following labeling
at the cell surface and then allowing endocytosis to proceed for
3 hrs at 37uC. As shown in Fig. 5A, KCa2.3 co-localized with WT
Rab5 after 3 hrs, whereas expression of DN Rab5 appears to slow
endocytosis in these experiments (Fig. 5B). Importantly, expression
of Q79L Rab5 resulted in KCa2.3 accumulating on the induced
vacuoles following endocytosis (Fig. 5C), clearly demonstrating
that KCa2.3 enters a Rab5 compartment during endocytosis. An
association between KCa2.3 and Rab5 was confirmed by co-IP as
shown in Fig. 5D. As shown, we were only able to co-IP KCa2.3
and Q79L Rab5 suggesting that the association between KCa2.3
and WT Rab5 is too transient to observe under these conditions,
whereas the dominant active form of Rab5 allowed this association
to become apparent.
If Rab5 is important for the endocytosis of KCa2.3 then it
would be predicted that in the steady-state S34N Rab5 would
increase KCa2.3 at the plasma membrane due to a decreased rate
of endocytosis. This was confirmed by cell surface biotinylations,
as shown in Fig. 6A. That is, expression of S34N Rab5 increased
plasma membrane KCa2.3 expression 2.3160.10-fold (p,0.05,
n = 3) relative to WT Rab5 expression (Fig. 6B). In contrast, Q79L
Rab5 had no effect on plasma membrane KCa2.3 expression
(1.0960.04-fold), indicating that the overall recycling pathway
back to the cells surface has not been compromised in these
studies. We confirmed these results by knocking down Rab5
expression using an siRNA-mediated approach. As shown, we
achieved almost 70% knockdown of Rab5 relative to a scrambled
siRNA control (Fig. 6C) which resulted in an approximately 2-fold
increase in cell surface expression of KCa2.3 (1.9060.32-fold,
n = 3; p,0.05; Fig. 6D).
Our results suggest that S34N Rab5 slows down the endocytosis
of KCa2.3 resulting in an increase in cell surface expression of the
channel. Thus, we directly evaluated the effect of Rab5 expression
on KCa2.3 endocytosis by biotinylating KCa2.3 at the plasma
membrane and determining the fraction of KCa2.3 endocytosed
after 20 min in the presence of WT or S34N Rab5. As shown in
Figure 4. DN dynamin II (K44A) slows down endocytosis of KCa2.3. A. BLAP-KCa2.3 was co-expressed with either WT or K44A dynamin II and
cell surface expression of the channel evaluated in triplicate as detailed in the Methods (top panel). Tubulin was used as a loading control (bottom
panel). The data were quantified by densitometry for three separate experiments and plotted as shown in B. Expression of K44A dynamin II resulted
in a significant increase in cell surface KCa2.3 expression (*p,0.05). C. BLAP-KCa2.3 was co-expressed with either WT or K44A dynamin II and
endocytosis of the channel assessed. Plasma membrane proteins were biotinylated using EZ-Link Sulfo-NHS-SS-Biotin (see Methods) after which the
cells were incubated at 37uC for 20 min. Initial plasma membrane expression was determined by omitting the 37uC incubation step (T = 0 min, lane
2). The cell surface biotin which remained following endocytosis was stripped (MESNA) after which the endocytosed, biotinylated protein was pulled
down using streptavidin-agarose, the proteins separated by SDS-PAGE and blotted for KCa2.3. The efficiency of stripping was determined by
subjecting cells to MESNA in the absence of a 37uC endocytosis step (control, lane 1). Lane 3 demonstrates the amount of KCa2.3 endocytosed in
20 min (T = 20 min). The ratio between the amount of KCa2.3 detected following endocytosis (lane 3) to that at time 0 (lane 2) was determined by
densitometry and plotted as % endocytosis in D. Expression of K44A dynamin resulted in a significant decrease of KCa2.3 endocytosis, relative to WT
dynamin (n = 3; *p,0.05). Densitometry is expressed as mean 6 SEM.
doi:10.1371/journal.pone.0044150.g004
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Fig. 7, in the presence of WT Rab5, 19.362.9% of KCa2.3 was
endocytosed and entered the recycling pool after 20 min, similar
to our results above as well as our previous observations [18]. In
contrast, in the presence of S34N Rab5 only 8.961.2% (p,0.05,
n = 3) of KCa2.3 was endocytosed after 20 min, directly demon-
strating that S34N Rab5 decreases the endocytosis of KCa2.3.
These results unequivocally demonstrate a role for Rab5 in the
endocytosis of plasma membrane KCa2.3.
Discussion
KCa2.3 plays a pivotal role in a host of physiological processes
such that understanding not only the regulation and gating of this
channel, but also its cell biology is imperative to fully appreciating
its role in the cells and tissues where it is expressed. Clearly, both
the open probability (Po) of a channel, as well as the number of
channels (N) in the membrane, when an agonist is present, is
deterministic in any physiological response. Very few studies,
however, have explored the mechanisms by which KCa2.3 is
either trafficked to the plasma membrane or the molecular
mechanisms by which this channel is retrieved from the cell
surface. Previously, we demonstrated that both an S4–S5 linker
lysine [13], as well as charged amino acids in the S3 and S4
transmembrane domains [32], are required for the correct
anterograde trafficking of KCa2.3 to the plasma membrane.
Further, we demonstrated that misfolded KCa2.3 channels
proteins are ubiquitylated and targeted to the proteasome in
a derlin-1 and p97-dependent fashion [32]. In addition, Roncarati
et al. [19] demonstrated an important role for the N-terminus, C-
terminus and the calmodulin binding domain of KCa2.3 in the
trafficking of KCa2.3 out of the endoplasmic reticulum. This latter
observation is consistent with observations that the calmodulin
binding domain is required for the correct trafficking of other
members of the small conductance Ca2+-activated K+ channels
[15,16].
An important first clue to the mechanism by which KCa2.3 is
retrieved from the plasma membrane came from the studies of
Absi et al. [22], as they demonstrated that KCa2.3 is localized to
caveolae in vascular endothelial cells. Recently, we demonstrated
that KCa2.3 is rapidly retrieved from the plasma membrane and
Figure 5. KCa2.3 enters Rab5 positive endosomes. BLAP-tagged KCa2.3 was co-expressed with DsRed-tagged WT (A), S34N (B) or Q79L (C)
Rab5 in HEK293 cells. KCa2.3 was labeled with streptavidin-Alexa488 and localization evaluated by confocal fluorescence after 0 or 3 hrs at 37uC.
KCa2.3 is localized to the plasma membrane at 0 hrs (upper panels) in each case, as expected. After 3 hrs (lower panels), endocytosed KCa2.3 co-
localizes with WT Rab5 (A) as is clear in the merge (yellow color), whereas S34N appears to slow endocytosis (B). As is apparent, Q79L Rab5a induces
the formation of intracellular vacuoles (C) and endocytosed KCa2.3 accumulates on these vacuoles; confirming co-localization of KCa2.3 and Rab5. D.
Co-IP of myc-tagged KCa2.3 with DsRed-tagged Rab5. KCa2.3 was immunoprecipitated using an anti-myc Ab (lanes 1, 2, 4, 5, 6) or an anti-V5 Ab as
IgG control (lane 3) and subsequently IB using an anti-Rab5 Ab. Q79L Rab5 was detected by IB (lane 6), confirming an association between KCa2.3
and Rab5. Note that an association was not detected between KCa2.3 and either WT or Q79L Rab5 suggesting these associations are very transient in
nature. Bottom Panel confirms equivalent Rab5 expression (20 mg total protein loaded per lane). Data are representative of 3 experiments.
doi:10.1371/journal.pone.0044150.g005
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enters a recycling compartment from which the channel is
returned to the plasma membrane with a time constant of
,5 min [18]. We further showed that the recycling of KCa2.3 was
dependent upon Rab35 as well as the Rab-GAP, EPI64C. Finally,
we demonstrated that a small domain within the cytoplasmic N-
terminus was critical to the recycling of KCa2.3 and that deletion
of this domain altered the association of a component of the
recycling endosome, RME-1 (EHD1) [18]. These studies left open
the question of what are the initial endocytic steps involved in the
trafficking of KCa2.3 from the plasma membrane to the recycling
endosomes.
The endocytosis of plasma membrane, as well as the resident
cargo, can be broadly divided in to phagocytosis or macro-
pinocytosis, clathrin-mediated endocytosis or pathways which are
generally referred to as clathrin-independent, including caveolae-
dependent endocytosis. Initially, we demonstrate that KCa2.3 is
localized to a caveolin-rich plasma membrane domain and that
the channel is endocytosed in caveolae using fluorescence and
TEM (Fig. 1A and B). Further, we demonstrate that KCa2.3 and
caveolin co-IP (Fig. 1C). Finally, using caveolin-1-deficient MEFs
cells, we observed that both KCa2.3 cell surface expression and
endocytosis are dependent upon caveolin (Fig. 2). These results
confirm and extend previous studies [22]; clearly demonstrating
that KCa2.3 is localized to lipid rafts in a caveolin-rich domain of
the plasma membrane and is endocytosed in to caveolae in
a caveolin-1-dependent manner.
The endocytosis of cargo within lipid rafts can be either
caveolin- and dynamin-dependent or dynamin-independent via
non-caveolar intermediates [33]. Given the association of KCa2.3
with caveolin that we (Fig. 1) and others [22] have observed, we
determined the role of dynamin in this process. As shown in
Fig. 3A, KCa2.3 co-localizes with dynamin II in endocyted
vesicles and co-IP confirms a close association between these
proteins (Fig. 3B). Moreover, expression of a DN dynamin (K44A)
resulted in an increase in steady-state plasma membrane KCa2.3
(Fig. 4A) as well as an inhibition of KCa2.3 endocytosis (Fig. 4C).
These results further support the proposal that KCa2.3 is localized
to lipid rafts and is endocytosed in a dynamin-dependent manner
in caveolae.
A further division in the early endocytic fate of numerous
proteins is based on the role that small GTPases play in the fusion
of membranes and hence vesicle formation. The small GTPase,
Arf6 has been shown to be involved in the early endocytosis and
recycling of non-clathrin-dependent cargo [34,35] while also being
shown to play a role in Rab35-dependent recycling [36,37]. As we
previously demonstrated that KCa2.3 recycling is dependent upon
Rab35 [18], we initially explored a role for Arf6 in the endocytosis
of KCa2.3. However, DN Arf6 did not cause any apparent
accumulation of KCa2.3 in an intracellular vacuolar compartment
following endocytosis (data not shown) as would be expected
[36,37], suggesting that while the endocytosis/recycling of KCa2.3
is Rab35 dependent it is independent of Arf6. Rather, our studies
support a role for Rab5 in the formation of KCa2.3 containing
vesicles during endocytosis and subsequent delivery to the
recycling endosomes. We demonstrate that KCa2.3 and Rab5
can be co-localized and also co-IP (Fig. 5A and D), indicative of
these proteins being within the same vesicular compartment. In
this regard, during steady-state endocytosis we observe approxi-
mately 20–30% of KCa2.3 in an intracellular compartment
(Fig. 7A), which would include both early endosomes and recycling
endosomes as well as any off-pathways, which have not been
characterized to date. However, we were only able to co-IP
Figure 6. Cell surface expression of KCa2.3 is dependent on Rab5. A. BLAP-KCa2.3 was co-expressed with either WT, Q79L or S34N Rab5 and
cell surface expression of the channel evaluated in duplicate as detailed in the Methods (top panel). Total KCa2.3 expression was also evaluated (total
lysate) with no apparent effect of Rab5 expression (A, bottom panel). The data for cell surface expression was quantified by densitometry for three
separate experiments and plotted as shown in B. Expression of S34N Rab5 resulted in a significant increase in cell surface KCa2.3 expression
(*p,0.05). C. BLAP-KCa2.3 was co-expressed with either control or Rab5 siRNA (siRab5) and cell surface expression of the channel evaluated (top
panel). Knockdown of Rab5 was confirmed by IB (middle panel). Tubulin was used as a loading control (bottom panel). The data for cell surface
expression was quantified by densitometry for three separate experiments and plotted as shown in D. Knockdown of Rab5 resulted in a significant
increase in cell surface KCa2.3 expression (*p,0.05). Densitometry is expressed as mean 6 SEM.
doi:10.1371/journal.pone.0044150.g006
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KCa2.3 with dominant active Rab5, which results in enlarged
endosomes such that KCa2.3 is trapped in an intracellular
compartment associated with Rab5 [38–40]. It is well-known that
Rabs associate with membranes in a GTP-dependent manner,
whereas the hydrolysis of GTP to GDP results in the Rab
dissociating from the membrane in to the cytosol [41]. Thus, our
inability to detect an association between KCa2.3 and the DN
Rab5 (S34N; GDP-bound) is expected due to its cytosolic
localization. We speculate that our inability to detect an
association between WT Rab5 and KCa2.3 is due to the transient
nature of this association or the fraction of KCa2.3 moving
through this compartment is too small to be routinely observed. In
contrast, the DA Rab5 (Q79L; GTP-bound) remains associated
with the endosomal membrane for an extended period thus
increasing the likelihood of observing this association. In addition
to demonstrating an association between KCa2.3 and Rab5, we
show that expression of a DN Rab5 or siRNA-mediated
knockdown of Rab5 results in an increase in plasma membrane
localized KCa2.3 (Fig. 6A and C) as expected if Rab5 plays a role
in the endocytosis of this channel. Finally, we directly demonstrate
that inhibition of Rab5 function resulted in a slowing of the
endocytosis of KCa2.3 (Fig. 7A); unequivocally demonstrating
a role for Rab5 in the endocytosis of KCa2.3.
The precise control of the number of any channel, including
KCa2.3, at the plasma membrane, N, is a key component of any
physiological response. Given the dynamic nature of KCa2.3 at
the plasma membrane any change in the rate constants for
endocytosis or recycling would be expected to have both rapid and
significant effects on the number of channels in the membrane.
Clearly, one potential modulator of these rate constants would be
agonists working through changes in either intracellular Ca2+ or
kinases. Indeed, activation of b1 adrenoceptors in amygdala
pyramidal neurons triggers activation of the PKA pathway, which
has been shown to interfere with KCa2.2 recycling, effectively
sequestering the channels into the cytosolic compartment [42]. It is
also interesting to speculate that pharmacological agents that
activate Ca2+-activated K+ channels through either an increase in
PoMAX or change in Ca
2+-affinity may also alter N by modulating
channel activity. Thus, understanding the mechanisms underlying
KCa2.3 endocytosis and recycling is critical to clarifying how these
channels alter the physiology of an organ system. Based on recent
reports, as well as the data herein, this is starting to come in to
focus leading us to propose the following mechanism: KCa2.3 is
localized to lipid rafts and is endocytosed in caveolae containing
Figure 7. DN Rab5 (S34N) retards endocytosis of KCa2.3. A.
BLAP-KCa2.3 was co-expressed with either WT or S34N Rab5 and
endocytosis of the channel assessed. Plasma membrane proteins were
biotinylated using EZ-Link Sulfo-NHS-SS-Biotin (see Methods) after
which the cells were incubated at 37uC for 20 min. Initial plasma
membrane expression was determined by omitting the 37uC incubation
step (T = 20 min, lane 2). The cell surface biotin which remained
following endocytosis was stripped (MESNA) after which the endocy-
tosed, biotinylated protein was pulled down using streptavidin-agarose,
the proteins separated by SDS-PAGE and blotted for KCa2.3. The
efficiency of stripping was determined by subjecting cells to MESNA in
the absence of a 37uC endocytosis step (control, lane 1). Lanes 3
demonstrates the amount of KCa2.3 endocytosed in 20 min
(T = 20 min). The ratio between the amount of KCa2.3 detected
following endocytosis (lane 3) to that at time 0 (lane 2) was determined
by densitometry and plotted as % endocytosis in B. Expression of S34N
Rab5 resulted in a significant decrease of KCa2.3 endocytosis, relative to
WT Rab5 (n=3; *P,0.05). Densitometry is expressed as mean 6 SEM.
doi:10.1371/journal.pone.0044150.g007
Figure 8. Schematic model for endocytosis and recycling of KCa2.3 based on data herein as well as our previous publication (18).
doi:10.1371/journal.pone.0044150.g008
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caveolin-1 in a dynamin-dependent manner. The small GTPase,
Rab5 is required for membrane fusion associated with KCa2.3
endocytosis after which the channel-containing vesicles are fused
with a Rab35-containing recycling compartment. Recycling back
to the plasma membrane occurs rapidly, with a time constant of
,5 min and is dependent upon Rab35 as well as the Rab-GAP,
EPI64C. Finally, this recycling is dependent upon a small N-
terminal domain whose absence leads to a decreased association
with RME-1 (EHD1) and subsequent more rapid degradation [18]
(Fig. 8). These results lead to several additional questions,
including whether the endocytosis and recycling of KCa2.3 is
associated with a cycle of ubiquitylation/deubiquitylation as has
been described for other ion channels that enter the recycling
pathway [43–45] and whether this post-translational modification
is manipulated physiologically as a means of altering N. In
addition, it will be important to define the components involved in
removing KCa2.3 from the recycling pathway and to determine
whether this channel is ultimately destined for ubiquitylation and
lysosomal degradation in a manner analogous to what we recently
described for KCa3.1 [20] or some other degradative fate.
Acknowledgments
The authors gratefully acknowledge Dr. Kirk Hamilton for critically
reading the manuscript and for many helpful conversations.
Author Contributions
Conceived and designed the experiments: YG CAB CMB SCW DCD.
Performed the experiments: YG CAB CMB. Analyzed the data: YG CAB
CMB SCW DCD. Contributed reagents/materials/analysis tools: SCW
DCD. Wrote the paper: CAB DCD. Critically reviewed manuscript prior
to submission: CAB CMB DCD.
References
1. Adelman JP, Maylie J, Sah P (2012) Small-conductance Ca2+-activated K+
channel: Form and function. Ann. Rev. Physiol. 74: 245–269.
2. Kohler R, Kaistha BP, Wulff H (2010) Vascular KCa-channels as therapeutic
targets in hypertension and restenosis disease. Expert. Opin. Ther. Targets.
14(2): 143–155.
3. Girault A, Haelters JP, Potier-Cartereau M, Chantome A, Jaffres PA, et al.
(2012) Targeting SKCa channels in cancer: Potential new therapeutic
approaches. Curr. Med. Chem. 19(5): 697–713.
4. Allen D, Fakler B, Maylie J, Adelman JP (2007) Organization and regulation of
small conductance Ca2+ -activated K+ channel multiprotein complexes. J.
Neurosci. 27(9), 2369–2376.
5. Bildl W, Strassmaier T, Thurm H, Andersen J, Eble S, et al. (2004) Protein
kinase CK2 is coassembled with small conductance Ca2+ -activated K+ channels
and regulates channel gating. Neuron 43(6), 847–858.
6. Frei E, Spindler I, Grissmer S, Jager H (2006) Interactions of N-terminal and C-
terminal parts of the small conductance Ca2+ -activated K+ channel, hSK3. Cell.
Physiol. Biochem. 18(4–5), 165–176.
7. Gerlach AC, Gangopadhyay NN, Devor DC (2000) Kinase-dependent
regulation of the intermediate conductance, calcium-dependent potassium
channel, hIK1. J. Biol. Chem. 275(1), 585–598.
8. Gerlach AC, Syme CA, Giltinan L, Adelman JP, Devor DC (2001) ATP-
dependent activation of the intermediate conductance, Ca2+ -activated K+
channel, hIK1, is conferred by a C-terminal domain. J. Biol. Chem. 276(14),
10963–10970.
9. Jones HM, Hamilton KL, Papworth GD, Syme CA, Watkins SC, et al. (2004)
Role of the NH2 terminus in the assembly and trafficking of the intermediate
conductance Ca2+ -activated K+ channel, hIK1. J. Biol. Chem. 279(15), 15531–
15540.
10. Srivastava S, Li Z, Ko K, Choudhury P, Albaqumi M, et al. (2006) Histidine
phosphorylation of the potassium channel KCa3.1 by nucleoside diphosphate
kinase B is required for activation of KCa3.1 and CD4 T Cells. Molecular Cell
24(5), 665–675.
11. Hamilton KL, Syme CA, Devor DC Molecular localization of the inhibitory
arachidonic acid binding site to the pore of hIK1. J. Biol. Chem. 278(19):
16690–16697, 2003.
12. Jones HM, Bailey MA, Baty CJ, MacGregor GG, Syme CA, et al. (2007) An
NH2-terminal multib RKR motif is required for the ATP-dependent regulation
of hIK1 Channels 1(2), 80–91.
13. Jones H M, Hamilton KL, Devor DC (2005) Role of an S4–S5 linker lysine in
the trafficking of the Ca2+ -activated K+ channel IK1 and SK3. J. Biol. Chem.
280(44), 37257–37265.
14. Syme CA, Hamilton KL, Jones H M, Gerlach AC, Giltinan L, et al. (2003)
Trafficking of the Ca2+ -activated K+ channel, hIK1, is dependent upon a C-
terminal leucine zipper. J. Biol. Chem. 278(10), 8476–8486.
15. Joiner WJ, Khanna R, Schlichter LC, Kaczmarek LK (2001) Calmodulin
regulates assembly and trafficking of SK4/IK1 Ca2+ -activated K+ channels. J.
Biol. Chem. 276(41), 37980–37985.
16. Lee WS, Ngo-Anh TJ, Bruening-Wright A, Maylie J, et al. (2003) Small
conductance Ca2+ -activated K+ channels and calmodulin. J. Biol. Chem.
278(28), 25940–25946.
17. Roncarati R, Decimo I, Fumagalli G (2005) Assembly and trafficking of human
small conductance Ca2+ -activated K+ channels SK3 are governed by different
molecular domains. Mol. Cell. Neurosci. 28(2), 314–325.
18. Gao Y, Balut CM, Bailey MA, Patino-Lopez G, Shaw S, et al. (2010) Recycling
of the Ca2+-activated K+ channel, KCa2.3 is dependent upon RME-1, Rab35/
EPI64C and an N-terminal domain. J. Biol. Chem. 285(23): 17938–17953.
19. Balut CM, Gao Y, Murray SA, Thibodeau PH, Devor DC (2010) ESCRT-
dependent targeting of plasma membrane localized KCa3.1 to the lysosomes.
Am. J. Physiol.: Cell Physiology. 299(5): C1015–1027.
20. Balut CM, Loch C, Devor DC (2011) Role of ubiquitylation and USP8-
dependent deubiquitylation in the endocytosis and lysosomal targeting of plasma
membrane KCa3.1. FASEB J. 25(11): 3938–3948.
21. Schwab A, Nechyporuk-Zloy V, Gassner B, Schultz C, Kessler W, et al. (2012)
Dynamic redistribution of calcium sensitive potassium channels (hKCa3.1) in
migrating cells. J. Cell Physiol. 227(2): 686–696.
22. Absi M, Burnham MP, Weston AH, Harno E, Rogers M, et al. (2007) Effects of
methyl beta-cyclodextrin on EDHF responses in pig and rat arteries; association
between SK(Ca) channels and caveolinn-rich domains. Br. J. Pharmacol. 151:
332–340.
23. Vonderheit A, Helenius A (2005) Rab7 associates with early endosomes to
mediate sorting and transport of Semliki forest virus to late endosomes. PLoS
Biol. 3(7): e233.
24. Sharma DK, Choudhury A, Singh RD, Wheatley CL, Marks DL, et al. (2003)
Glycosphingolipids internalized by vaeolar-related endocytosis rapidly merge
with the clathrin pathway in early endosomes and form microdomains for
recycling. J. Biol. Chem. 278(9): 7564–7572.
25. van Heyningen S (1974) Cholera toxin: interaction of subunits with ganglioside
GM1. Science 183: 656–657.
26. Parton RG (1994) Ultrastructural localization of gangliosides; GM1 is
concentrated in caveolae. J. Histol. Cytol. 42: 155–166.
27. Shaul PW, Anderson RG (1998) Role of plasmalemmal caveolae in signal
transduction. Am. J. Physiol.: Lung Cell Mol Physiol 275: L843–L851.
28. Cohen AW, Hnasko R, Schubert W, Lisanti MP (2004) Role of caveolae and
caveolins in health and disease. Physiol. Rev. 84(4): 1341–79.
29. Mayor S, Pagano RE (2007) Pathways of clathrin-independent endocytosis. Nat.
Rev. Mol. Cell Biol. 8(8): 603–612.
30. Grant BD, Donaldson JG (2009) Pathways and mechanisms of endocytic
recycling. Nat. Rev. Mol. Cell Biol. 10: 597–608.
31. Donaldson JG, Porat-Shliom N, Cohen LA (2009) Clathrin-independent
endocytosis: A unique platform for cell signaling and PM remodeling. Cellular
Signaling 21: 1–6.
32. Gao Y, Chotoo CK, Balut CM, Sun F, Bailey MA, et al. (2008) Role of S3 and
S4 transmembrane domain charged amino acids in channel biogenesis and
gating of KCa2.3 and KCa3.1. J. Biol. Chem. 283(14): 9049–9059.
33. Kumari S, Swetha MG, Mayor S (2010) Endocytosis unplugged: Multiple ways
to enter the cell. Cell Research 20: 256–275.
34. Brown FD, Rozelle AL, Yin HL, Balla T, Donaldson JG (2001) Phosphatidy-
linositol 4,5-bisphosphate and Arf6-regulated membrane traffic. J. Cell Biol. 154:
1007–1017.
35. Delaney KA, Murph MM, Brown LM, Radhakrishna H (2002) J. Biol. Chem.
277: 33439–33446.
36. Chesneau L, Dambournet D, Machicoane M, Kouranti I, Fukuda M, et al.
(2012) An ARF6/Rab35 GTPase cascade for endocytic recycling and successful
cytokinesis. Curr. Biol. 22(2): 147–153.
37. Rahajeng J, Panapakkam Giridharan SS, Cai B, Naslavsky N, Caplan S (2012)
MICAL-L1 is a tubular endosomal membrane hub that connects Rab35 and
Arf6 with Rab8a. Traffic. 13(1): 82–93.
38. Bucci C, Parton RG, Mather IH, Stunnenberg H, Simons K, et al. (1992) The
small GTPase rab5 functions as a regulatory factor in the early endocytic
pathway. Cell 70: 715–728.
39. Stenmark H, Parton RG, Steele-Mortimer O, Luetcke A, Gruenberg J, et al.
(1994) Inhibition of rab5 GTPase activity stimulates membrane fusion in
endocytosis EMBO J. 13: 1287–1296.
40. Barbieri MA, Li G, Mayorga LS, Stahl PD (1996) Characterization of
Rab5:Q79L-stimulated endosome fusion. Arch. Biochem. Biophys. 326: 64–72.
41. Ng EL, Gan BQ, Ng F, Tang BL (2012) Rab GTPases regulating receptor
trafficking at the late endosome-lysosome membranes. Cell Biochem Funct. doi:
10.1002/cbf.2827.
Endocytosis of KCa2.3
PLOS ONE | www.plosone.org 10 August 2012 | Volume 7 | Issue 8 | e44150
42. Faber ES, Delaney AJ, Power JM, Sedlak PL, Crane JW, et al. (2008)
Modulation of SK channel trafficking by beta adrenoceptors enhances excitatory
synaptic transmission and plasticity in the amygdala. J. Neurosci. 28, 10803–
10813.
43. Bomberger JM, Barnaby RL, Stanton BA (2010) The deubiquitinating enzyme
USP10 regulates the endocytic recycling of CFTR in airway epithelial cells.
Channels 4(3): 150–154.
44. Staub O, Gautschi I, Ishikawa T, Breitschopf K, Ciechanover A, et al. (1997)
Regulation of stability and function of the epithelial Na+ channel (ENaC) by
ubiquitination. EMBO J. 16(21): 6325–6336.
45. Butterworth MB, Edinger RS, Ovaa H, Burg D, Johnson JP, et al. (2007) The
deubiquitinating enzyme UCH-L3 regulates the apical membrane recycling of
the epithelial sodium channel. J. Biol. Chem. 282(52): 37885–37893.
Endocytosis of KCa2.3
PLOS ONE | www.plosone.org 11 August 2012 | Volume 7 | Issue 8 | e44150
